Literature DB >> 7893879

Cellular transport of drugs.

T H Steinberg1.   

Abstract

The ability of drugs to enter cells and to reach an adequate concentration within the appropriate intracellular compartment may be an important determinant of the efficacy of therapy for infections due to intracellular pathogens. Antibiotics vary considerably in their ability to accumulate within cells. All solutes can be taken up by endocytosis, and some compounds reach high intracellular concentrations after crossing the plasma membrane by diffusion or by specific transport processes. Cellular organelles have properties that affect the intracellular distribution of drugs and that may account for the net accumulation of drugs within cells. An important example is the ability of acidic organelles to trap lysosomotropic weak bases. Cells also express transport proteins that may limit the intracellular accumulation of drugs by secreting them across the plasma membrane into the extracellular medium. Thus, cellular organic anion transporters can decrease the intracellular accumulation of certain antibiotics, and the multidrug-resistance transporter, or p-glycoprotein, confers resistance to antineoplastic agents. Inhibition of organic anion transport may have therapeutic value. A better appreciation of the mechanisms by which drugs accumulate within cells and within specific intracellular compartments may lead to the design of agents that reach higher concentrations at clinically relevant intracellular sites.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7893879     DOI: 10.1093/clinids/19.5.916

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  9 in total

1.  Comparison of bronchopulmonary pharmacokinetics of clarithromycin and azithromycin.

Authors:  K B Patel; D Xuan; P R Tessier; J H Russomanno; R Quintiliani; C H Nightingale
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

2.  Discrepancy between uptake and intracellular activity of moxifloxacin in a Staphylococcus aureus-human THP-1 monocytic cell model.

Authors:  Delphine Paillard; Jean Grellet; Véronique Dubois; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 3.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

4.  Cellular pharmacokinetics and pharmacodynamics of the glycopeptide antibiotic oritavancin (LY333328) in a model of J774 mouse macrophages.

Authors:  Françoise Van Bambeke; Stéphane Carryn; Cristina Seral; Hugues Chanteux; Donatienne Tyteca; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

5.  Intracellular activities of RP 59500 (quinupristin-dalfopristin) and sparfloxacin against Enterococcus faecium.

Authors:  I Herrera-Insúa; K Jacques-Palaz; B E Murray; R M Rakita
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

6.  Polymeric prodrugs of antibiotics with improved efficiency.

Authors:  E Roseeuw; V Coessens; E Schacht; B Vrooman; D Domurado; G Marchal
Journal:  J Mater Sci Mater Med       Date:  1999-12       Impact factor: 3.896

7.  Structural and transcriptional analyses of a purine nucleotide-binding protein from Pyrococcus furiosus: a component of a novel, membrane-bound multiprotein complex unique to this hyperthermophilic archaeon.

Authors:  Brian Gerwe; Laura-Lee Clancy Kelley; Bret D Dillard; Thomas Lai; Zhi-Jie Liu; Wolfram Tempel; Lirong Chen; Jeff Habel; Doowon Lee; Francis E Jenney; Frank J Sugar; Jane S Richardson; David C Richardson; M Gary Newton; Bi-Cheng Wang; Michael W W Adams; John P Rose
Journal:  J Struct Funct Genomics       Date:  2007-10-12

8.  Quantitative assessment of cytosolic Salmonella in epithelial cells.

Authors:  Leigh A Knodler; Vinod Nair; Olivia Steele-Mortimer
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

Review 9.  Prodrugs for the treatment of neglected diseases.

Authors:  Man Chin Chung; Elizabeth Igne Ferreira; Jean Leandro Santos; Jeanine Giarolla; Daniela Gonçales Rando; Adélia Emília Almeida; Priscila Longhin Bosquesi; Renato Farina Menegon; Lorena Blau
Journal:  Molecules       Date:  2007-03-19       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.